🕵️ Biote Corp. ($BTMD)
SEC insider & ownership activity, last 12 months · CIK 1819253 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. Agarwal Amit Mohan added 5.9% → 7.6%. No red-flag 8-Ks in the window.
Insider flow
1 buyer, value withheld pending verification (2 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Marc D. Beer | 2 | value withheld pending verification | 0 | – | Aug 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Richard Barrera | 14.0% | 13D | Jun 5, 2025 | filing ↗ | |
| Roystone Management Holdings LLC | 14.0% | 13D | Jun 5, 2025 | filing ↗ | |
| RB Management GP LLC | 14.0% | 13D | Jun 5, 2025 | filing ↗ | |
| Guines LLC | 14.0% | 13D | Jun 5, 2025 | filing ↗ | |
| Agarwal Amit Mohan | 7.6% | Class A | 13G | Sep 1, 2026 | filing ↗ |
| Bandera Partners LLC | 6.4% | 13G | May 13, 2026 | filing ↗ | |
| Bylinsky Gregory | 6.4% | 13G | May 13, 2026 | filing ↗ | |
| Gramm Jefferson | 6.4% | 13G | May 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Earnings (2.02) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Other events (8.01) | Jan 26, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |